AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 212 min read$MOH

Molina: Q3 Earnings Snapshot

Molina Healthcare (MOH) reported Q3 net income of $38M, or 73 cents per share, beating analyst estimates of 72 cents. Revenue was $11.08B, exceeding expectations of $10.93B. The company forecasts full-year earnings of $5.25 per share and revenue of $42B.

Original reporting
finance.yahoo.com
Published Oct 21, 2026, 8:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Molina: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$MOHBullishHigh
01

Why it matters

The earnings beat could trigger short-term buying interest and may influence analyst revisions.

02

Market read

First-quarter earnings beat provides a fresh catalyst for MOH and may affect related health‑care stocks.

03

What to watch

Potential impact of upcoming policy changes or Medicaid enrollment trends not addressed in the release.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Molina Healthcare is a U.S. managed care company focused on Medicaid and Medicare Advantage programs.

Company-level read

Ticker impact

$MOHBullishHigh confidence
Context

Molina Healthcare reported Q3 earnings beating estimates with EPS of $0.73 vs $0.72 expected and revenue of $11.08B vs $10.93B forecast.

Expected impact

upward pressure as the market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded consensus, indicating stronger performance than expected.

Market effects

Sector

Positive earnings may lift other Medicaid service providers and health insurers.

Regional

U.S. healthcare sector may see modest gains.

Global

Limited to U.S. markets; no broader global effect.

Counterpoint

What could challenge this read

Investors may question sustainability of growth given regulatory pressures on Medicaid reimbursements.

Key entities

  • Company
    Molina Healthcare Inc.

    Provider of Medicaid-related health services.

Read at source← All news

StoryMolina Healthcare posts Q3 2026 earnings drop, beats estimates and reaffirms full‑year guidance

Also covered by

5 outlets

Related articles

OCT 21
$MOHHighAI 8/10

Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimates

Molina Healthcare (MOH) reported Q3 2026 revenue of $11.08B, down 3.4% YoY but exceeding estimates by 2%. Adjusted operating margin was 1.2%, and EPS was $0.89, down from last year but beating estimates. Analysts project 9% revenue growth and 311% EPS growth over the next 12 months. The stock fell 4.1% post-results.

finance.yahoo.com2 min
OCT 21
$MOHHighAI 8/10

Molina Healthcare falls 4% on challenging environment, despite beating third quarter estimates

Molina Healthcare (NYSE:MOH) reported Q3 earnings of $0.89 per share, beating estimates by $0.10, with revenue at $11.08B, down 4% YoY. Shares fell 4.6% due to margin pressures and a challenging environment. The company reaffirmed its 2026 guidance of at least $5.25 per share. Membership and premium revenue declined due to lower Medicaid and Marketplace enrollment.

investing.com2 min
OCT 21
$MOHHigh

Molina Healthcare Reports Third Quarter 2026 Financial Results

MOLINA HEALTHCARE, INC. (MOH) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Investor Contact: Jeffrey Geyer, Jeffrey.Geyer@molinahealthcare.com , 305-317-3012 Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com , 562-542-1845 Molina Healthcare Reports Third Quarter 2026 Financial Results Reaffirms Full Year 2026 Earnings G

SEC EDGAR 8-K2 min
OCT 21
$MOHMedAI 8/10

Molina Healthcare, Inc. (MOH) Q3 EPS Down, Guidance Reaffirmed

Molina Healthcare (MOH) reported Q3 2026 GAAP EPS of $0.73 and adjusted EPS of $0.89, both down ~53% YoY, on $10.5B premium revenue (down 4%). The company reaffirmed 2026 guidance, including at least $2.38 GAAP EPS and $5.25 adjusted EPS. Management cited high medical costs as a pressure point but signaled potential stabilization.

tradingview.com2 min